Stock Track | TransMedics Soars 5.18% Intraday on Tax Benefit Boosting Q4 Earnings

Stock Track

Feb 27

Shares of TransMedics Group, Inc. surged 5.18% during intraday trading on Friday, following the company's disclosure of a significant one-time tax benefit that dramatically improved its fourth-quarter financial results.

The medical technology company issued additional information regarding the impact of releasing a $103.3 million U.S. tax valuation allowance in the fourth quarter of 2025. This action resulted in a net income tax benefit of $83.8 million for the quarter.

Consequently, TransMedics reported fourth-quarter net income of $105.4 million, with diluted earnings per share of $2.62. The company noted that its full-year 2025 effective tax rate was (77.0)%, but excluding the impact of the valuation allowance release, the rate would have been 19.1%. TransMedics expects future quarterly income tax provisions to align more closely with standard U.S. statutory corporate income tax rates.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1190510354"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1190510354\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1190510354?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-27 23:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1190510354","market":"nz","top_or_hot":-1,"title":"Stock Track | TransMedics Soars 5.18% Intraday on Tax Benefit Boosting Q4 Earnings","media":"Stock Track","content":"<p>Shares of TransMedics Group, Inc. surged 5.18% during intraday trading on Friday, following the company's disclosure of a significant one-time tax benefit that dramatically improved its fourth-quarter financial results.</p><p>The medical technology company issued additional information regarding the impact of releasing a $103.3 million U.S. tax valuation allowance in the fourth quarter of 2025. This action resulted in a net income tax benefit of $83.8 million for the quarter.</p><p>Consequently, TransMedics reported fourth-quarter net income of $105.4 million, with diluted earnings per share of $2.62. The company noted that its full-year 2025 effective tax rate was (77.0)%, but excluding the impact of the valuation allowance release, the rate would have been 19.1%. TransMedics expects future quarterly income tax provisions to align more closely with standard U.S. statutory corporate income tax rates.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | TransMedics Soars 5.18% Intraday on Tax Benefit Boosting Q4 Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | TransMedics Soars 5.18% Intraday on Tax Benefit Boosting Q4 Earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-27 23:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of TransMedics Group, Inc. surged 5.18% during intraday trading on Friday, following the company's disclosure of a significant one-time tax benefit that dramatically improved its fourth-quarter financial results.</p><p>The medical technology company issued additional information regarding the impact of releasing a $103.3 million U.S. tax valuation allowance in the fourth quarter of 2025. This action resulted in a net income tax benefit of $83.8 million for the quarter.</p><p>Consequently, TransMedics reported fourth-quarter net income of $105.4 million, with diluted earnings per share of $2.62. The company noted that its full-year 2025 effective tax rate was (77.0)%, but excluding the impact of the valuation allowance release, the rate would have been 19.1%. TransMedics expects future quarterly income tax provisions to align more closely with standard U.S. statutory corporate income tax rates.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TMDX","symbol_name":"Transmedics Group","start_time":0,"source_url":"","article_id":"1190510354","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1190510354","pubTimestamp":1772206016,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of TransMedics Group, Inc. surged 5.18% during intraday trading on Friday, following the company's disclosure of a significant one-time tax benefit that dramatically improved its...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TMDX":"Transmedics Group"},"translate_title":"个股追踪|税收优惠提振Q4盈利TransMedics盘中大涨5.18%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TMDX":1},"content_text":"Shares of TransMedics Group, Inc. surged 5.18% during intraday trading on Friday, following the company's disclosure of a significant one-time tax benefit that dramatically improved its fourth-quarter financial results.The medical technology company issued additional information regarding the impact of releasing a $103.3 million U.S. tax valuation allowance in the fourth quarter of 2025. This action resulted in a net income tax benefit of $83.8 million for the quarter.Consequently, TransMedics reported fourth-quarter net income of $105.4 million, with diluted earnings per share of $2.62. The company noted that its full-year 2025 effective tax rate was (77.0)%, but excluding the impact of the valuation allowance release, the rate would have been 19.1%. TransMedics expects future quarterly income tax provisions to align more closely with standard U.S. statutory corporate income tax rates.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}